Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-032983
Filing Date
2022-05-31
Accepted
2022-05-31 19:44:53
Documents
1
Period of Report
2022-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2376
  Complete submission text file 0001209191-22-032983.txt   3996
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3000 WESTERN AVENUE SUITE 400 SEATTLE WA 98121
Business Address 3000 WESTERN AVENUE SUITE 400 SEATTLE WA 98121 425-220-2542
CBI USA, Inc. (Reporting) CIK: 0001930189 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39011 | Film No.: 22985383